
Twenty pending bids for ASX companies show buyers paying large premiums for small caps. What the discount means for investors.
~ 2 min. read
By: Datt Capital
Dealogic counts 20 pending takeover deals for Australian listed companies, worth US$62.3 billion, and nearly all of them involve small caps. Buyers who do their own valuation work are paying well above the share market’s price for these businesses. At the same time, Australian small caps are trading at one of their widest discounts to large caps in years. We discussed the connection at our webinar on 18 November, and it says a lot about where value sits in the market today.
Year to date, the S&P/ASX 100 has risen 6.31% while the S&P/ASX Small Ordinaries has fallen 12.25%. Returns have come from a narrow group of large companies and AI-related exposures, leaving small caps about three P/E points below large caps on forward earnings.
The causes are structural. Active small-cap managers have closed, and passive investing has grown. Index funds allocate new money by size: of every $100 in an ASX 200 index fund, about $8 reaches companies ranked 101 to 200. With fewer investors researching small companies closely, share prices can drift further from what the businesses are worth.
A wide discount does not guarantee that prices will recover. The structural forces behind it will not reverse quickly, so small caps could stay cheap for some time.
Takeovers have limits for investors too. A bid at a large premium to a depressed share price can still fall short of what a business is worth. Bids for companies an investor does not own lift the index, but not that investor’s returns. And as companies are taken over and few new ones list, the pool of small companies to choose from shrinks.
Possible changes to capital gains tax and higher interest rates could also weigh on the sector next year.
Private equity and strategic acquirers are already acting on these valuations. This week, Nuix received a takeover bid at a 73% premium, and Mayne Pharma received a binding bid at a 99% premium.
Buyers paying this much have done their own valuation work and reached a different answer from the share market. A weaker Australian dollar also makes Australian companies cheaper for offshore buyers, which adds to the appeal of the discount.
If the structural forces persist, the discount is more likely to close one company at a time, through bids, than through a broad recovery across the sector. The gains would then go mainly to investors who own the businesses that acquirers want.
That makes stock selection more important than index exposure. Owning the Small Ordinaries means owning the companies that bidders pass over as well as those they pursue.
The Datt Small Companies Fund holds between 15 and 25 stocks. Each is selected for balance sheet strength, cash generation or hard-asset backing, and several are scarce or strategic assets of the kind that industry buyers look for.
A concentrated fund will not own every takeover target. The aim is to own businesses that are worth holding on their fundamentals, whether or not a bid arrives.
Australian small caps are trading at a rare discount for structural reasons, and buyers outside the share market are paying large premiums to capture it. In our view, today’s valuations favour investors with a medium-term horizon who are selective about which small companies they own.
To learn more about how we invest in Australian small caps, visit our [Small Companies Fund page] or contact our Distribution Manager, Daniel Liptak, at 0419 004 524 or by email at daniel@datt.com.au.
Sources: S&P Dow Jones Indices, year to date as at 11 November 2026; Bloomberg and Datt Capital, 12-month forward P/E; Dealogic, as at 18 November 2026; ASX company announcements. This article contains general information only and does not take into account your objectives, financial situation or needs. Past performance is not a reliable indicator of future performance.
Disclaimer: This article does not take into account your investment objectives, particular needs or financial situation; and should not be construed as advice in any way. The author may hold stocks discussed in this article. Forward-looking statements reflect the author's views at the time of writing and are subject to change. Past performance is not indicative of future results.